Search

everythinglearnresearchcommunity

for

Search:↓

Early diagnosis and treatment of PCOS is crucial to reduce emotional distress and health risks.

Effective treatments for excessive hair growth in women include creams, laser therapy, and medications, with the choice depending on individual needs and potential side effects.

The document concludes that hirsutism can be managed with various treatments tailored to the individual, potentially improving quality of life.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Different anti-androgen medications can help treat excessive hair growth, but the right choice depends on accurate diagnosis.

Androgen excess disorders in women were effectively treated with spironolactone, estrogen, and dexamethasone.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

Excessive body hair in women can be caused by various conditions and treated with medication like Diane® 35 or androgen blockers.

Some plant-based treatments may help with ovary function, insulin resistance, and excess male hormones in PCOS, but more research is needed to confirm their safety and effectiveness.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

New treatments for male hypogonadism are effective and should be personalized.

Common acne treatments can cause various side effects, like skin irritation and more serious issues, but combination therapies are often more effective and better tolerated.

Finasteride reduces hirsutism effectively with fewer side effects but is a second-choice treatment due to safety concerns.

Hirsutism causes significant psychological distress in women.

Testosterone treatment can improve sexual function and bone density in women but may have adverse effects and requires more research on safety and guidelines.

Cyproterone acetate is the preferred treatment for women's hyperandrogenism when estrogen/progestogen use is safe.

The document concludes that effective acne treatment requires a personalized combination of therapies and long-term commitment, with retinoids being important for maintenance.

Combining letrozole with metformin is the most effective treatment for inducing pregnancy in women with PCOS.

Hormonal treatments can help with hair loss, acne, and excess hair growth, but it takes 3-6 months to see results and patients should know the possible side effects.

The conclusion is that the best initial treatment for hirsutism is usually oral contraceptives, with the addition of antiandrogens or insulin sensitizers if needed, and topical eflornithine or laser treatments as supplementary options.

Diane 35 plus finasteride is more effective for treating hirsutism.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

The document concludes that combination therapy is most effective for treating excessive hair growth in women with idiopathic hirsutism, and more research is needed to understand the condition.

Hormonal changes and psychological issues can cause sexual dysfunction in postmenopausal women. Behavioral therapy is recommended first, with hormone replacement helping some symptoms but not libido. Testosterone can improve libido, but its effects on overall sexual function are unclear. Emotional and relationship issues should be addressed before using medication, and the benefits and risks of testosterone supplementation should be considered.

The guide recommends specific methods for diagnosing PCOS and various treatments for its symptoms, while considering the health impacts on adolescents.

Neurosteroids show promise for treating epilepsy and more research is needed.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Cyclophosphamide has serious side effects, but long-term follow-up can help manage risks.

The review concludes that more research is needed to better improve the health outcomes for people with Polycystic Ovarian Syndrome.